Targeting Notch signaling pathway to overcome drug resistance for cancer therapy

Zhiwei Wang1, Yiwei Li, Aamir Ahmad

  • 1Department of Pathology, Karmanos Cancer Institute, Wayne State University, School of Medicine, Detroit, MI 48201, USA. zhiweiwang@med.wayne.edu

Insights

Chemotherapy resistance in cancer is a major challenge. Targeting the Notch signaling pathway with natural agents may overcome this resistance, improving cancer treatment outcomes.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Chemotherapy is a cornerstone of cancer treatment but often fails due to drug resistance, leading to tumor recurrence.
  • Drug resistance in cancer cells is a significant clinical challenge, limiting the efficacy of chemotherapeutic agents.
  • The Notch signaling pathway has been implicated as a key regulator in the development of chemoresistance.

Purpose of the Study:

  • To review the role of the Notch signaling pathway in chemotherapy resistance.
  • To explore the potential of targeting the Notch pathway to overcome drug resistance.
  • To summarize the use of natural agents in modulating Notch signaling for improved cancer therapy.

Main Methods:

  • Literature review of studies investigating Notch signaling in drug-resistant cancer cells.
  • Analysis of evidence linking Notch pathway activity to chemoresistance mechanisms.
  • Compilation of research on natural compounds that target the Notch pathway.

Main Results:

  • The Notch signaling pathway plays a crucial role in mediating intrinsic and acquired chemoresistance.
  • Down-regulation of Notch signaling can restore sensitivity to chemotherapy drugs.
  • Natural agents show promise in inhibiting Notch signaling and enhancing anti-cancer effects.

Conclusions:

  • The Notch pathway is a critical determinant of chemotherapy response in various malignancies.
  • Targeting Notch signaling represents a promising strategy to overcome cancer drug resistance.
  • Natural agents offer a potentially safer therapeutic approach to modulate Notch activity and improve cancer treatment efficacy.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...